Registry study for recent high-risk blood clot in the lungs
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial is a registry that collects information about people with a recent lung blood clot diagnosed by CT scan. It particularly focuses on higher-risk cases to better understand outcomes and care in the first 2 weeks after symptoms start.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your lung blood clot (pulmonary embolism) must be confirmed by a CT scan with contrast (CT pulmonary angiography).
- Your symptoms must have started 14 days or less ago.
- You must be in a higher-risk group, such as having very unstable circulation (cardiac arrest, shock, or ongoing low blood pressure).
- Alternatively, you may qualify if your heart’s right side is under strain (right ventricle dysfunction on imaging) and a blood test called troponin is elevated.
- You must be willing to sign the informed consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing if repeated imaging can help monitor blood clots in the lungs (pulmonary embolism) over time. It may help doctors know how well treatment is working and if further care is needed.
This study records information about people who have had a pulmonary embolism, so researchers can learn how patients do over time. It may help improve understanding of outcomes and care patterns for future patients.
This trial looks at how people do after an acute pulmonary embolism (a blood clot in the lungs). It aims to understand real-world outcomes over follow-up and may help improve how care teams track patients after treatment.
This trial tests a new catheter-based device to break up blood clots in the lungs for people with a moderate-risk pulmonary embolism (PE). The goal is to see if it can improve blood flow and reduce strain on the heart.
This real-world study compares different treatment approaches for pulmonary embolism (PE)—a serious blood clot in the lung arteries—in patients who are stable but at intermediate-to-high risk of complications. The goal is to understand which treatments work best and safest in everyday practice.
This trial studies a structured pulmonary (lung) rehabilitation program for people who still have breathing and activity problems after a pulmonary embolism (PE). It may help improve physical ability and function during recovery.
Hear when a new Pulmonary Embolism With Acute Cor Pulmonale trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.